ITGAX and Sepsis: In our present study, it was found that GTS-21 treatment decreased the maturation of DCs and the release of DC-related pro-inflammatory cytokines in vitro and in sepsis-induced ALI mouse model and reduced the quantity of CD11c+MHCII+ cDCs and CD11c+CD11b+ cDCs2 in vivo experiment.